2017
Preoperative optimization for major hepatic resection
Walcott-Sapp S, Billingsley KG. Preoperative optimization for major hepatic resection. Langenbeck's Archives Of Surgery 2017, 403: 23-35. PMID: 29150719, DOI: 10.1007/s00423-017-1638-x.Peer-Reviewed Original ResearchConceptsMajor hepatic resectionHepatic resectionExercise capacityLiver diseaseMajor liver resectionUnderlying liver diseaseChronic liver diseasePrimary hepatobiliary malignanciesPathophysiology of changesPreoperative preparation programHepatectomy patientsPreoperative optimizationExercise toleranceMajor hepatectomyPostoperative complicationsLiver resectionMetastatic diseasePostoperative outcomesHepatobiliary malignanciesPreoperative evaluationExercise programExercise trainingFatty infiltrationHepatic steatosisMuscle strength
2013
Safety and Outcomes Following Resection of Colorectal Liver Metastases in the Era of Current Perioperative Chemotherapy
Gur I, Diggs B, Wagner J, Vaccaro G, Lopez C, Sheppard B, Orloff S, Billingsley K. Safety and Outcomes Following Resection of Colorectal Liver Metastases in the Era of Current Perioperative Chemotherapy. Journal Of Gastrointestinal Surgery 2013, 17: 2133-2142. PMID: 24091909, DOI: 10.1007/s11605-013-2295-1.Peer-Reviewed Original ResearchConceptsColorectal liver metastasesPreoperative chemotherapyPerioperative chemotherapyOverall survivalLiver metastasesAdvanced ageResectable colorectal liver metastasesPreoperative portal vein embolizationShorter disease-free intervalAcademic oncology centerOutcomes Following ResectionThirty-day mortalityDisease-free intervalHigh-risk patientsPortal vein embolizationSubset of patientsPoor overall survivalLiver recurrenceSynchronous diseaseEleven patientsPostoperative complicationsRepeat resectionLiver resectionVein embolizationRetrospective review
2008
Does Surgeon Case Volume Influence Nonfatal Adverse Outcomes after Rectal Cancer Resection?
Billingsley K, Morris A, Green P, Dominitz J, Matthews B, Dobie S, Barlow W, Baldwin L. Does Surgeon Case Volume Influence Nonfatal Adverse Outcomes after Rectal Cancer Resection? Journal Of The American College Of Surgeons 2008, 206: 1167-1177. PMID: 18501815, PMCID: PMC3103396, DOI: 10.1016/j.jamcollsurg.2007.12.042.Peer-Reviewed Original ResearchConceptsSurgeon volumeSurgeon ageProcedural interventionEnd Results (SEER) cancer registry programNonfatal adverse outcomesRectal cancer careMajor postoperative complicationsRectal cancer resectionEnd Results (SEER) dataCancer Registry ProgrammeRectal cancer patientsRectal cancer surgeryRetrospective cohort designHigh-volume surgeonsRectal cancer operationsPostoperative complicationsColorectal surgeryHospital volumeSurgical complicationsCancer resectionPrimary outcomeRectal cancerSevere complicationsCancer surgeryCancer operations
2007
Reoperation as a Quality Indicator in Colorectal Surgery
Morris A, Baldwin L, Matthews B, Dominitz J, Barlow W, Dobie S, Billingsley K. Reoperation as a Quality Indicator in Colorectal Surgery. Annals Of Surgery 2007, 245: 73-79. PMID: 17197968, PMCID: PMC1867944, DOI: 10.1097/01.sla.0000231797.37743.9f.Peer-Reviewed Original ResearchConceptsColorectal cancer patientsPostoperative proceduresPatient characteristicsCancer patientsProcedural interventionColorectal cancer surgeryAcute medical conditionsSEER-Medicare databaseLength of stayIntermediate outcome measuresQuality Improvement ProgramNonfatal complicationsAdjusted riskBowel perforationEmergent admissionPostoperative complicationsPostoperative interventionsWound complicationsAbdominal infectionColorectal surgeryOrgan injuryProlonged hospitalizationCancer surgeryTumor characteristicsEarly mortality
2006
Complications and Antireflux Medication Use After Antireflux Surgery
Dominitz J, Dire C, Billingsley K, Todd–Stenberg J. Complications and Antireflux Medication Use After Antireflux Surgery. Clinical Gastroenterology And Hepatology 2006, 4: 299-305. PMID: 16527692, DOI: 10.1016/j.cgh.2005.12.019.Peer-Reviewed Original ResearchConceptsAntireflux medication useAntireflux surgeryMedication useAntireflux medicationVeterans Affairs administrative databasesPredictors of complicationsGastroesophageal reflux diseaseMore outpatient visitsSurgical mortality rateHealth care useH2-receptor antagonistsPostoperative complicationsPromotility agentsReflux diseasePharmacy recordsOutpatient visitsEsophageal cancerReceptor antagonistCare useAdministrative databasesMultiple prescriptionsComplicationsPatientsMortality rateSurgery